World Health Organization & Bayer
4 shared events · Importance 3 · Last updated Jun 26, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
World Health Organization: Its IARC classified glyphosate as probably carcinogenic in 2015, a finding cited by plaintiffs but not adopted by EPA.
Bayer: Bayer is the primary beneficiary; the ruling shields it from thousands of failure-to-warn lawsuits, reducing litigation risk and boosting investor confidence. Shares rose ~18%.
Jun 25, 2026 · 133 articles
Regulatory
World Health Organization: The World Health Organization is referenced through its cancer research arm's 2015 glyphosate classification, which helped spark the Roundup litigation.
Bayer: Bayer is the central party seeking court approval of the $7.25 billion settlement to resolve roughly 65,000 Roundup claims; approval would remove a major legal overhang and support its turnaround, while rejection would prolong litigation and weigh on its shares.
Sep 11, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how World Health Organization and Bayer interact across events, view sentiment trends, and discover connected entities.
Open Dashboard